Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2026-01-16 @ 8:23 PM
Study NCT ID:
NCT02716012
Status:
UNKNOWN
Last Update Posted:
2025-03-10
First Post:
2016-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
Sponsor:
Mina Alpha Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MNA-3521-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None